One of the world's leading research institutes, our scientists are working to advance understanding of biological processes at the molecular level - providing the knowledge needed to solve key problems in human health.

3D structure of PI3Kdelta: An important drug target for a wide range of diseases

Published on 13 January, 2010

“Intellikine announced today the publication of an article entitled, “The p110delta structure: mechanisms for selectivity and potency of new PI(3)K inhibitors,” now available as an advanced online publication at Nature Chemical Biology…The pioneering work was the result of a collaboration led by Roger Williams, Ph.D., Professor in the Laboratory of Molecular Biology at the Medical Research Council in Cambridge, U.K., and it included scientists from the University of California, San Francisco, Intellikine in La Jolla, California, and Merck-Serono Research Center in Geneva, Switzerland.” More…